Richard Hébert
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Ion Transport and Channel Regulation 20
- Receptor Mechanisms and Signaling 10
- Physiology 33
- Nitric Oxide and Endothelin Effects 15
- Smoking Behavior and Cessation 12
- Co-authors
- Rania Nasrallah (33 shared papers)Rhian M. Touyz (9 shared papers)Mona Sedeek (5 shared papers)Matthew D. Breyer (11 shared papers)C. Kennedy (21 shared papers)H R Jacobson (4 shared papers)Kevin D. Burns (12 shared papers)John P. Bent (5 shared papers)
- Journals
- American Journal of Physiology-Renal Physiology (22 papers)Nicotine & Tobacco Research (12 papers)Clinical Science (5 papers)Prostaglandins Leukotrienes and Essential Fatty Acids (4 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Richard Hébert
102 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 129
- Nephrology 657
- Biochemistry 490
- Clinical Biochemistry 276
- Pharmacology 572
- Endocrinology, Diabetes and Metabolism 505
Countries citing papers authored by Richard Hébert
This map shows the geographic impact of Richard Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hébert more than expected).
Fields of papers citing papers by Richard Hébert
This network shows the impact of papers produced by Richard Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hébert. The network helps show where Richard Hébert may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Hébert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 387 | |
| 2 | 2010 | 328 | |
| 3 | 2009 | 136 | |
| 4 | 2012 | 134 | |
| 5 | 1998 | 122 | |
| 6 | 1991 | 113 | |
| 7 | 1990 | 113 | |
| 8 | 1993 | 108 | |
| 9 | 1998 | 100 | |
| 10 | 2012 | 97 | |
| 11 | 2009 | 94 | |
| 12 | 1998 | 84 | |
| 13 | 2015 | 81 | |
| 14 | 1992 | 79 | |
| 15 | 2018 | 77 | |
| 16 | 2007 | 75 | |
| 17 | 2005 | 73 | |
| 18 | 1992 | 67 | |
| 19 | 1978 | 66 | |
| 20 | 1999 | 65 |
About Richard Hébert
Richard Hébert is a scholar working on Molecular Biology, Physiology, Pharmacology, Biochemistry and Pulmonary and Respiratory Medicine, having authored 104 papers that have together received 3.5k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (20 papers), Eicosanoids and Hypertension Pharmacology (18 papers), Inflammatory mediators and NSAID effects (16 papers), Nitric Oxide and Endothelin Effects (15 papers), Electrolyte and hormonal disorders (13 papers), Smoking Behavior and Cessation (12 papers), Receptor Mechanisms and Signaling (10 papers) and Hormonal Regulation and Hypertension (8 papers). The work is most often cited by research in Nephrology (657 citations), Biochemistry (490 citations), Clinical Biochemistry (276 citations), Pharmacology (572 citations) and Endocrinology, Diabetes and Metabolism (505 citations). Richard Hébert has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Rania Nasrallah, Rhian M. Touyz, Mona Sedeek, Matthew D. Breyer, C. Kennedy, H R Jacobson, Kevin D. Burns, John P. Bent, Joseph Zimpelmann and S. P. Nadler. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Nicotine & Tobacco Research, Clinical Science, Prostaglandins Leukotrienes and Essential Fatty Acids and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.